The government will pay $210 million for the doses, which Eli Lilly will ship by the end of March.
Tag: Drugs (Pharmaceuticals)
Your Wednesday Briefing
Syria’s economy in distress.
F.D.A. Authorizes Another Antibody Treatment
Researchers hope Eli Lilly’s new combination therapy will be better able to fight virus variants than a similar treatment already in use.
Solidarity Is Not an Easy Sell as E.U. Lags in Vaccine Race
Europe’s collective vaccine purchase is an experiment in deeper integration. Despite a rocky start, many countries still stand to benefit, but it’s the most powerful who have least to gain.
US Health Experts: Vaccines Will Increase by Spring
Officials are racing to vaccinate as many people as possible in order to outpace more contagious variants of the virus that were first identified in Britain and South Africa.
Israel’s Covid Vaccination Results Point a Way Out of Pandemic
Covid cases fell dramatically and quickly among people who were vaccinated, Israeli studies found. It’s the strongest evidence yet that a robust vaccination program can tame the pandemic.
Top E.U. Official Comes Under Fire in Vaccine Wars
Ursula von der Leyen has largely stayed away from the limelight while driving the handling of a crisis and letting subordinates take the blame.
Top E.U. Official Comes Under Fire in Vaccine Wars
Ursula von der Leyen has largely stayed away from the limelight while driving the handling of a crisis and letting subordinates take the blame.
As Virus Variants Spread, ‘No One Is Safe Until Everyone Is Safe’
Rich countries are cornering the market on coronavirus vaccines, leaving poorer regions as potential breeding grounds for variants, like one found in South Africa, that could make vaccines less effective.
Vaccine Shortages Hit E.U. in a Setback for Its Immunization Race
Spain has suspended vaccinations in Madrid because of a shortfall of doses, as the European Union locks horns with the drugmaker AstraZeneca over vaccine delivery cuts.